The Make-or-Buy Decision for Cell and Gene Therapy Manufacturing: Implications for Overcoming Manufacturing Bottlenecks and Challenges

This panel from BDO USA features leaders from up-and-coming biopharmaceutical companies to examine “make or buy” decision-making for manufacturing of advanced therapies. Moderator Stephen Orosz (managing director at BioProcess Technology Group, BPTG, part of BDO USA) led the discussion with Heikki Jouttijärvi (senior vice president of manufacturing and supply chain management at Adverum Biotechnologies), Adam Haskett (senior director and head of external manufacturing for Cargo Therapeutics), David Fontana (chief business and operating officer at Umoja Biopharma), and Brad Stewart (market managing principal and national life-sciences leader at BDO USA).

Register or Login and hit Watch on Demand to view the recorded panel discussion now.